Indole-3-carbinol induces tumor cell death: function follows form

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Colorectal cancer (CRC) remains a leading cause of cancer death despite advances in screening and treatment.
• Current CRC chemotherapeutics often have significant side effects or limited efficacy.
• Dietary phytochemicals, like indole-3-carbinol (I3C), are emerging as potential natural chemotherapeutics for CRC.

Purpose of the Study:

• To investigate the role of aryl hydrocarbon receptor (AHR) activation in the cytotoxic effects of indole-3-carbinol (I3C) on colorectal cancer cells.
• To characterize the mechanism by which I3C exerts its anti-cancer properties.

Main Methods:

• Human colorectal cancer cell lines were treated with I3C or a vehicle control.
• Cell viability was assessed using a fluorescent product assay.
• Apoptotic activity was measured by caspase-3 and caspase-7 activity.
• Gene expression of AHR and CYP1A1 (an AHR marker) was quantified using qRT-PCR.
• AHR function was inhibited using small interfering RNA (siRNA) to assess its role in I3C's effects.

Main Results:

• I3C treatment led to increased CYP1A1 mRNA levels in multiple CRC cell lines, confirming AHR pathway activation.
• I3C demonstrated a dose-dependent reduction in cell viability and induced apoptosis.
• Knockdown of AHR using siRNA significantly reduced I3C's cytotoxic and pro-apoptotic effects, indicating AHR dependency.

Conclusions:

• The cytotoxic and pro-apoptotic effects of I3C on colon cancer cells are, in part, dependent on AHR activation.
• This study reveals a novel mechanism for I3C's action in colorectal cancer.
• Further preclinical research on I3C and the AHR pathway may lead to new diet-derived CRC treatments.